期刊文献+

对中高危高血压患者葡萄糖耐量试验异常的干预研究 被引量:1

Interventional research of the abnormality of glucose tolerance test in patients with middle to high-risk primary hypertension
原文传递
导出
摘要 目的观察对葡萄糖耐量试验异常的中高危高血压患者进行干预12个月后血压及糖代谢的情况。方法对213例葡萄糖耐量减低(IGT)的高血压患者随机分为生活方式控制组(LC)、生活方式控制加二甲双胍组(LC+M)、生活方式控制加阿卡波糖组(LC+A)三组,分析干预12个月后各组IGT转化为正常葡萄糖耐量(NGT)和新发糖尿病(DM)的发生率以及血压与IGT、NGT、DM之间的关系。结果三组干预12个月后,2hPG均明显降低(P<0.01),与LC组比,LC+M组和LC+A组转为NGT的人数均明显增多(P<0.01),LC+M组和LC+A组相比,在转为NGT和DM的人数方面差异无统计学意义(P>0.05),且血压越达标,糖尿病发生率越低。结论对糖耐量异常的高血压患者,积极的进行干预,可以减少糖尿病的发生,生活方式控制加药物治疗优于单纯生活方式控制。 Objective To observe the change in blood pressure and glucose metabolism in middle to high-risk hypertension patients with impaired glucose tolerance (IGT) after 12--months of intervention. Methods 213 patients with hypertension were randomized into three intervention groups: lifestyle improvement (LI)group, metformin plus LI(MLI) group, and acarbose plus LI(ALI) group. After 12 months of intervention, the converting rate of IGT to normal glucose tolerance (NGT) and the incidence of newly diagnosed diabetes (DM) were investigated, and relationships of blood pressure with IGT, NGT, DM were analyzed. Results All intervention of three groups are effective. The case number of group MLI and ALI converting to NGT were significantly more than that of LC(P〈0. 01). Compared with group MLI and goup ALI, there were no significant differences in the converted case number of to NGT(P〉 0.05). And the more standard blood pressure, the lower incidence of diabetes. Conclusions Active intervention can decrease the incidence of diabetes in middle to high-risk hypertension patients with IGT, and addition of life style controlling to drug intervention results in better therapeutic effects.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第10期764-766,共3页 Chinese Journal of Diabetes
关键词 原发性高血压 糖耐量异常 干预 Primary hypertension Glucose tolerance abnormality Intervention
  • 相关文献

参考文献6

二级参考文献24

共引文献71

同被引文献30

  • 1方懿珊,李统艺,陈师毅.药物与非药物干预对糖耐量减低者结局的影响:5年随访[J].中国临床康复,2004,8(30):6562-6563. 被引量:6
  • 2梁强,邬磊,刘鹏鹰.糖耐量减退患者的药物干预效果[J].实用医技杂志,2004,11(10A):1947-1949. 被引量:2
  • 3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [ J ]. The New England Journal of Medicine, 2010, 362 (12): 1090 -1101.
  • 4Pan CY, Gao Y, Chen JW, et al. Efficacy of acarbose in Chinese subjects with impaired glucose tolerance [ J ]. Diabetes Research and Clinical Practice, 2003, 61 (3) : 183 -190.
  • 5张景义,张海泉,杨春雨,等.阿卡波糖对糖耐量减低的干预治疗[J].中国临床医药,2004,5(4):18-19.
  • 6季文,荣青峰.阿卡波糖对葡萄糖耐量减低患者的干预治疗观察[J].临床药学实践,2009,18(11):844-845.
  • 7官常荣,陈日秋.阿卡波糖治疗糖耐量异常患者的临床观察[J].中国医师,2011,14(1):106-107.
  • 8Vivian A, Identification and treatment of prediabetes to prevent pro- gression to type2 diabetes [J]. Clinical Comerstone, 2007, 9 (2) : 51 -61.
  • 9Krieger JW, Sitern HS, Daniels M], et al. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta- regression 1 [ J]. Am J Clin Nutr, 2006, 83 (2): 260-274.
  • 10Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes [ J]. Annu Rev Nutr, 2005, 25 (6): 435-468.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部